{
"info": {
"nct_id": "NCT01850147",
"official_title": "Study of Efficacy and Safety of Sequential Low-dose Sunitinib With Chemotherapy in Advanced Non-small Cell Lung Cancer After Failure of Conventional Regimen",
"inclusion_criteria": "* Histologic or cytologic diagnosis of stage IIIB/IV NSCLC\n* ECOG PS: 0,1\n* Unidimensional or bi-dimensional measurable disease\n* Receive prior treatment including first-line platinum-based chemotherapy, standard second-line chemotherapy and 1 EGF/EGFR inhibitor\n* Evidence of disease progression\n* Life expectancy >12 weeks\n* Neutrophils > 1.5 109/l, Platelets > 100 109/l, Hemoglobin > 9g/dl, Total bilirubin < 1.5 UNL, AST (SGOT) and ALT (SGPT) < 2.5 UNL, Alkaline phosphatases < 5 UNL, Creatinine < 1 UNL\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Pre-existing hemoptysis of a severity > grade 3 by NCI CTCAE criteria within 4 weeks prior to study entry\n* Uncontrolled hypertension\n* CHF, angina or arrhythmias\n* LVEF < 1 UNL\n* Existing a second malignancy within 5 years\n* Infected with HIV",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Histologic or cytologic diagnosis of stage IIIB/IV NSCLC",
"criterions": [
{
"exact_snippets": [
"Histologic or cytologic diagnosis"
],
"criterion": "diagnosis method",
"requirement_type": "type",
"expected_value": [
"histologic",
"cytologic"
]
},
{
"exact_snippets": [
"stage IIIB/IV NSCLC"
],
"criterion": "NSCLC stage",
"requirement_type": "stage",
"expected_value": [
"IIIB",
"IV"
]
}
]
},
{
"line": "* ECOG PS: 0,1",
"criterions": [
{
"exact_snippets": [
"ECOG PS"
],
"criterion": "ECOG performance status",
"requirement_type": "value",
"expected_value": [
"0",
"1"
]
}
]
},
{
"line": "* Unidimensional or bi-dimensional measurable disease",
"criterions": [
{
"exact_snippets": [
"Unidimensional or bi-dimensional measurable disease"
],
"criterion": "disease",
"requirement_type": "measurability",
"expected_value": [
"unidimensional",
"bi-dimensional"
]
}
]
},
{
"line": "* Receive prior treatment including first-line platinum-based chemotherapy, standard second-line chemotherapy and 1 EGF/EGFR inhibitor",
"criterions": [
{
"exact_snippets": [
"Receive prior treatment including first-line platinum-based chemotherapy"
],
"criterion": "first-line platinum-based chemotherapy",
"requirement_type": "prior treatment",
"expected_value": true
},
{
"exact_snippets": [
"Receive prior treatment including",
"standard second-line chemotherapy"
],
"criterion": "standard second-line chemotherapy",
"requirement_type": "prior treatment",
"expected_value": true
},
{
"exact_snippets": [
"Receive prior treatment including",
"1 EGF/EGFR inhibitor"
],
"criterion": "EGF/EGFR inhibitor",
"requirement_type": "prior treatment",
"expected_value": true
}
]
},
{
"line": "* Evidence of disease progression",
"criterions": [
{
"exact_snippets": [
"Evidence of disease progression"
],
"criterion": "disease progression",
"requirement_type": "evidence",
"expected_value": true
}
]
},
{
"line": "* Life expectancy >12 weeks",
"criterions": [
{
"exact_snippets": [
"Life expectancy >12 weeks"
],
"criterion": "life expectancy",
"requirement_type": "duration",
"expected_value": {
"comparisons": [
{
"operator": ">",
"value": 12
}
]
}
}
]
},
{
"line": "* Neutrophils > 1.5 109/l, Platelets > 100 109/l, Hemoglobin > 9g/dl, Total bilirubin < 1.5 UNL, AST (SGOT) and ALT (SGPT) < 2.5 UNL, Alkaline phosphatases < 5 UNL, Creatinine < 1 UNL",
"criterions": [
{
"exact_snippets": [
"Neutrophils > 1.5 109/l"
],
"criterion": "neutrophils",
"requirement_type": "count",
"expected_value": {
"operator": ">",
"value": 1.5
}
},
{
"exact_snippets": [
"Platelets > 100 109/l"
],
"criterion": "platelets",
"requirement_type": "count",
"expected_value": {
"operator": ">",
"value": 100
}
},
{
"exact_snippets": [
"Hemoglobin > 9g/dl"
],
"criterion": "hemoglobin",
"requirement_type": "level",
"expected_value": {
"operator": ">",
"value": 9
}
},
{
"exact_snippets": [
"Total bilirubin < 1.5 UNL"
],
"criterion": "total bilirubin",
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 1.5
}
},
{
"exact_snippets": [
"AST (SGOT) and ALT (SGPT) < 2.5 UNL"
],
"criterion": "AST (SGOT)",
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 2.5
}
},
{
"exact_snippets": [
"AST (SGOT) and ALT (SGPT) < 2.5 UNL"
],
"criterion": "ALT (SGPT)",
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 2.5
}
},
{
"exact_snippets": [
"Alkaline phosphatases < 5 UNL"
],
"criterion": "alkaline phosphatases",
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 5
}
},
{
"exact_snippets": [
"Creatinine < 1 UNL"
],
"criterion": "creatinine",
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 1
}
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": [
"Healthy volunteers allowed"
],
"criterion": "healthy volunteers",
"requirement_type": "participation",
"expected_value": true
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": [
"minimum age of 18 Years"
],
"criterion": "age",
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18
}
}
]
}
],
"exclusion_lines": [
{
"line": "* Pre-existing hemoptysis of a severity > grade 3 by NCI CTCAE criteria within 4 weeks prior to study entry",
"criterions": [
{
"exact_snippets": [
"Pre-existing hemoptysis",
"severity > grade 3"
],
"criterion": "hemoptysis",
"requirement_type": "severity",
"expected_value": {
"comparisons": [
{
"operator": ">",
"value": 3
}
]
}
},
{
"exact_snippets": [
"within 4 weeks prior to study entry"
],
"criterion": "time since hemoptysis",
"requirement_type": "duration",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 4
}
]
}
}
]
},
{
"line": "* Uncontrolled hypertension",
"criterions": [
{
"exact_snippets": [
"Uncontrolled hypertension"
],
"criterion": "hypertension",
"requirement_type": "control status",
"expected_value": "uncontrolled"
}
]
},
{
"line": "* CHF, angina or arrhythmias",
"criterions": [
{
"exact_snippets": [
"CHF"
],
"criterion": "CHF",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"angina"
],
"criterion": "angina",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"arrhythmias"
],
"criterion": "arrhythmias",
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"line": "* LVEF < 1 UNL",
"criterions": [
{
"exact_snippets": [
"LVEF < 1 UNL"
],
"criterion": "LVEF",
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 1
}
}
]
},
{
"line": "* Existing a second malignancy within 5 years",
"criterions": [
{
"exact_snippets": [
"Existing a second malignancy within 5 years"
],
"criterion": "second malignancy",
"requirement_type": "existence",
"expected_value": true
},
{
"exact_snippets": [
"within 5 years"
],
"criterion": "time since second malignancy",
"requirement_type": "duration",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 5
}
]
}
}
]
},
{
"line": "* Infected with HIV",
"criterions": [
{
"exact_snippets": [
"Infected with HIV"
],
"criterion": "HIV infection",
"requirement_type": "presence",
"expected_value": true
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}